Seouleaguer Co., Ltd. announced that it expects to receive KRW 5 billion in funding
January 16, 2020
Share
Seouleaguer Co., Ltd. (KOSDAQ:A043710) announced a private placement of 4,000,000 common shares at an issue price of KRW 1,250 per share for gross proceeds of KRW 5,000,000,000 on January 17, 2020. The transaction will involve participation from KS Medical Corporation. The shares have face value of KRW 500. The shares are issued at a discount of 10%. The shares issued in the transaction will have a hold period of 12 months from the date of issuance. The company will issue shares through third-party allotment method. Post the closing, the total number of shares issued by the company will increase from 29,515,308 shares to 33,515,308 shares. The payment date is February 3, 2020. The transaction has been approved by the board of directors of the company.
SEOULEAGUER CO., LTD, formerly ROCKETMOBILE CO., LTD, is a Korea-based company principally engaged in the drug sales business. The Company operates its business through four segments. The Healthcare Business segment distributes medicines and cosmetics. The Management Service Organization (MSO) Business segment involves in the advertising and real estate lease business. The Medical Business segment provides medical services such as skin care. The Mobile Accessory segment offers mobile accessories and peripherals including cases, cradles, chargers, bluetooth and others.
Seouleaguer Co., Ltd. announced that it expects to receive KRW 5 billion in funding
marketscreener.com**derivatives**en**/dynamic-chart/**Premium**Expert**Access**Annual**Monthly**All transcripts on over 9000 companies, on the day they post their earnings!**#ffffff**/services/solutions/**#004EFF**#000000**Unlock them now!**1**